EUVIMEDEUVIMED entdecken
Crossref

Antitumor effects of isoliquiritin on oral squamous cell carcinoma by VEGFC/FLT4-PI3K/AKT signaling axis

Yiwen Qin, Han Wu, Yinyu Wang, Ziqiao Zhuang, Fengyuan Ma, Sihao Chen, Zhaorong Xiao, He Shi, Dongxu Wang, Weiwei Liu

Cellular Signalling · 2027-01 · 149 · 112863

DOI: 10.1016/j.cellsig.2026.112863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2027-01. Verfasst von Yiwen Qin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun 130021, China. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Jilin Provincial Science and Technology Department, Natural Science Foundation of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: As a principal flavonoid glycoside derived from Glycyrrhiza uralensis, isoliquiritin (ISLT) has exerted notable anti-tumor activity in multiple solid malignancies including lung and liver cancers. This study aims to investigate the therapeutic effect and mechanism of ISLT on oral squamous cell carcinoma (OSCC). METHODS: CCK-8, colony formation and Ki67 were used to detect the effect on cell proliferation. The cytotoxic effects were detected by flow cytometry and Live/Dead cell staining. The effects on cell migration and invasion were detected by scratch and invasion assays. Further, the key molecule of ISLT in the treatment of OSCC, Fms Related Receptor Tyrosine Kinase 4 (FLT4), commonly termed vascular endothelial growth factor receptor 3 (VEGFR3), was further identified by transcriptome sequencing combined with molecular docking. Subsequently, FLT4 knockdown cells were constructed, and the regulatory effects and downstream molecular mechanisms of FLT4 on OSCC cells were determined by cell phenotype detection and protein expression level changes. Finally, OSCC mouse models were constructed to demonstrate the therapeutic efficacy and biological safety of ISLT in vivo. RESULTS: The results demonstrated that ISLT inhibited the proliferation of OSCC cells in a dose-dependent manner, with a significant inhibitory effect observed at 20 μg/mL. ISLT increased the apoptosis rate and exerted a marked killing effect on OSCC cells, also significantly suppressed the migration and invasion of OSCC cells with high metastatic and invasive potential. At the gene expression level, treatment with ISLT significantly upregulated the mRNA levels of P53, Bax and Caspase-3, while downregulating Bcl-2 expression, leading to an elevated Bax/Bcl-2 ratio. FLT4, the target of ISLT, was screened by transcriptome sequencing and molecular docking. Research has found that FLT4 knockdown can also significantly inhibit the proliferation, migration and invasion of OSCC cells, and can also promote apoptosis. At the protein level, the changes in the expression levels of apoptosis-related proteins after FLT4 knockdown were consistent with the trend caused by ISLT. Furthermore, studies on downstream molecular mechanisms showed that after FLT4 knockdown, the phosphorylation levels of phosphatidylinositol 3-kinase (PI3K) and protein kinase B (AKT) are significantly downregulated, resulting in decreased phosphorylated PI3K (p-PI3K)/PI3K and phosphorylated AKT (p-AKT)/AKT ratios. Finally, in vivo studies have shown that ISLT can significantly reduce the tumor volume of OSCC without causing any organ toxicity. CONCLUSION: This study reveals that ISLT has anti-tumor activity against OSCC, providing new insights into the traditional Chinese medicine treatment of human cancers.

Schlagwörter

Stichwörter der Autor:innen

FLT4IsoliquiritinOral squamous cell carcinomaVEGFC

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun 130021, China.
  • Academy of Stomatology, Baicheng Medical College, Baicheng 137000, China.
  • Laboratory Animal Center, College of Animal Science, Jilin University, Changchun 130062, China. Electronic address: wang_dong_xu@jlu.edu.cn.
  • Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun 130021, China. Electronic address: liuweiw@jlu.edu.cn.

Förderung

  • Jilin Provincial Science and Technology Department
  • Natural Science Foundation of Jilin Province

Zitieren

APA

Qin, Y., Wu, H., Wang, Y., Zhuang, Z., Ma, F., Chen, S., Xiao, Z., Shi, H., Wang, D., & Liu, W. (2027). Antitumor effects of isoliquiritin on oral squamous cell carcinoma by VEGFC/FLT4-PI3K/AKT signaling axis. Cellular Signalling, 149, 112863. https://doi.org/10.1016/j.cellsig.2026.112863

Vancouver

Qin Y, Wu H, Wang Y, Zhuang Z, Ma F, Chen S, et al. Antitumor effects of isoliquiritin on oral squamous cell carcinoma by VEGFC/FLT4-PI3K/AKT signaling axis. Cellular Signalling. 2027;149:112863. doi:10.1016/j.cellsig.2026.112863

BibTeX
@article{Qin2027,
  author = {Qin, Yiwen and Wu, Han and Wang, Yinyu and Zhuang, Ziqiao and Ma, Fengyuan and Chen, Sihao and Xiao, Zhaorong and Shi, He and Wang, Dongxu and Liu, Weiwei},
  title = {Antitumor effects of isoliquiritin on oral squamous cell carcinoma by VEGFC/FLT4-PI3K/AKT signaling axis},
  journal = {Cellular Signalling},
  year = {2027},
  volume = {149},
  pages = {112863},
  doi = {10.1016/j.cellsig.2026.112863}
}
Kostenlos starten →